Objective: To explore the network structure and potential causal relationship between psychological resilience and adjustment disorders among college students, so as to provide a basis for effective prevention and intervention on adjustment disorders. Methods: A longitudinal survey was conducted in September 2024 (T1) on 1 028 freshmen from 3 universities selected using convenient sampling method in Jiangsu Province, and a follow up survey was conducted in September 2025 (T2). The Connor-Davidson Resilience Scale (CD-RISC) and the Adjustment Disorder-New Module 20 (ADNM-20) Scale were used to evaluate psychological resilience and adjustment disorders. Network analysis method was employed to construct a symptom network of psychological resilience and adaptation disorders, and cross lagged panel network analysis was used to explore the longitudinal causal relationship. Results: At T1, the scores of psychological resilience and adjustment disorders for college students were (76.44±21.91) and (32.79±12.87). At T2, they were (77.45±22.38) and (28.27±11.38), respectively. The longitudinal network analysis results showed that there was a stable negative bidirectional predictive relationship between individual ability and maladjustment (T1 individual ability → T2 maladjustment: β =-0.12; T1 maladjustment → T2 individual ability: β =-0.17; both P <0.01). The node strength between tolerating negative emotions (T1:1.21, T2:1.30) and excessive worry (T1:1.20, T2:1.20) was the greatest, and impulse disturbance was the most robust bridge symptom connecting psychological resilience and adjustment disorder symptoms (T1:0.11, T2:0.08). Conclusion By improving individual ability and focusing on the intervention of core bridge symptoms such as over attention and impulsivity, the negative impact of psychological resilience issues on college students adaptation disorders can be reduced.

With the advent of precision medicine and personalized treatment, targeted therapies have become pivotal in oncology. Noninvasive molecular imaging, especially immunoPET/SPECT, plays a crucial role in refining cancer diagnostics and treatment monitoring by visualizing biological processes at the molecular level. This review explores the dynamic field of immunoPET/SPECT imaging using Fab and F(ab')₂ fragments, characterized by advantageous pharmacokinetics and swift clearance from the bloodstream, making them suitable for same-day imaging procedures. We examine contemporary strategies for radiolabeling these fragments with PET and SPECT radionuclides and discuss potential advancements and the challenges anticipated in the further development of Fab and F(ab')₂ fragments. Despite the complexities involved in their development, these fragments hold significant promise for advanceing personalized cancer treatment. Keys to this advancement are innovative radiolabeling techniques, site-specific conjugation chemistries, and short-lived radionuclides, all of which are crucial for overcoming existing limitations and enhancing the clinical utility of these imaging agents. As research progresses, Fab and F(ab')₂ fragments are expected to become central to the future of cancer diagnostics and therapeutic monitoring, thereby improving patient management and contributing significantly to the evolution of personalized medicine.